ArticleNano research2022

Hydroxyapatite nanoparticles drive the potency of Toll-like receptor 9 agonist for amplified innate and adaptive immune response.

Qin Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.